Cmpk1 (NM_001025655) Rat Tagged ORF Clone Lentiviral Particle

CAT#: RR200622L4V

  • LentiORF®

Lenti ORF particles, Cmpk1 (GFP-tagged ORF) - Rat cytidine monophosphate (UMP-CMP) kinase 1, cytosolic (Cmpk1), 200ul, >10^7 TU/mL



Need custom lentivirus service?
Get a free quote

CNY 8,360.00


货期*
详询

规格
    • 200 ul

Product images

经常一起买 (2)
Lenti ORF control particles of pLenti-C-mGFP-P2A-Puro, >1x10^7 TU/ml, 0.5 ml
    • 500 ul

CNY 2,950.00


One-Wash Lentivirus Titer Kit, HIV-1 p24 ELISA
    • 96 reactions

CNY 5,230.00

Specifications

Product Data
Product Name Cmpk1 (NM_001025655) Rat Tagged ORF Clone Lentiviral Particle
Synonyms CK; Cmpk; RGD1310116
Vector pLenti-C-mGFP-P2A-Puro
ACCN NM_001025655
ORF Size 681 bp
Sequence Data
The ORF insert of this clone is exactly the same as(RR200622).
OTI Disclaimer The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
OTI Annotation This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.
Reference Data
RefSeq NM_001025655.1, NP_001020826.1
RefSeq Size 1871 bp
RefSeq ORF 684 bp
Locus ID 298410
Gene Summary Catalyzes the phosphorylation of pyrimidine nucleoside monophosphates at the expense of ATP. Plays an important role in de novo pyrimidine nucleotide biosynthesis. Has preference for UMP and CMP as phosphate acceptors. Also displays broad nucleoside diphosphate kinase activity.[UniProtKB/Swiss-Prot Function]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...